The initial management of multiple myeloma in the era of novel agents: 2021 and beyond

Br J Haematol. 2021 Apr;193(2):213-215. doi: 10.1111/bjh.17407. Epub 2021 Mar 21.

Authors

Omar Nadeem¹, Paul G Richardson¹

Affiliation

¹ Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MD, USA.

PMID: 33748954
DOI: 10.1111/bjh.17407

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Multiple Myeloma* / drug therapy
Transplantation, Autologous